Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Judopay Partners with MedPoint to Enable Socially-distanced Payment and Collection of Prescriptions
Judopay, the leading mobile-centric and fully cloud based payments provider, today announced its partnership with MedPoint, […]
Nuevocor Closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies
Nuevocor, a preclinical-stage biotech company specializing in gene therapy for cardiomyopathies, has announced the completion […]
Mnemo Therapeutics Announces €75 million Series A to Accelerate Next Generation Integrated CAR-T and Epigenetic Targeting Platform
Mnemo Therapeutics, a biotechnology company developing powerful cell therapies using a novel target identification engine, […]
Medable Hires Sanskriti Thakur as Chief Growth Officer to Lead Market Expansion
Medable Inc., the leading cloud platform for patient-centered drug development, today announced the hiring of Sanskriti […]
Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development
Apollo Therapeutics, a portfolio-based biopharmaceutical company rapidly advancing potentially transformative treatments based on breakthrough discoveries, […]
Spring Health Announces Harshit Shah as New Chief Technology Officer
Spring Health, a leading provider of behavioral health benefits with the most comprehensive solution for […]
BASMA.com Raises a $3M Series a Round to Scale Up Its Health Tech Platform in the MENA
BASMA.com is a digital healthcare platform working on redefining the orthodontics support experience with a […]
Synaptogenix Announces $12.5 Million Private Placement
Synaptogenix, Inc. (Nasdaq: SNPX), an emerging biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced […]
Qure.ai ’s Brain CT AI Wins Funding from the NHS
The UK Department of Health and Social Care announced that Qure.ai has been selected as […]
Harbour BioMed and Dana-Farber Cancer Institute Collaborate to Advance Novel Biotherapies for Cancer Treatment
Harbour BioMed (HKEX: 02142) announced today it has entered into a multi-year, multifaceted research collaboration […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more